Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus

Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus

Background and Objectives: Belimumab (BEL) is a monoclonal antibody approved for the treatment of active systemic lupus erythematosus (SLE) but not for lupus nephritis (LN) and neuropsychiatric systemic lupus erythematosus (NPSLE). We aimed to assess BEL's effects on these severe, potentially l...

Full description

Bibliographic Details
Main Authors: Marlene Plüß, Björn Tampe, Noah Niebusch, Michael Zeisberg, Gerhard A. Müller, Peter Korsten
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Medicine
Subjects:
systemic lupus erythematosus
lupus nephritis
neuropsychiatric lupus erythematosus
belimumab
monoclonal antibodies
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2020.00222/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2020.00222/full

Similar Items